News and presentations

The ARCHERY study recruited its first participant on 27 December 2023. The participant was recruited into the cervical cancer cohort at the University Malaya Medical Centre in Malaysia, the first site to be open to recruitment into the study.  ARCHERY is a prospective observational study using artificial intelligence (AI) to improve radiotherapy planning to treat cancer. The ...

The University Malaya Medical Centre in Kuala Lumpur, Malaysia becomes the first recruiting site to be opened in the ARCHERY study. Congratulations and thank you to Dr Malik and her team! Visit our “Recruiting sites” page to find out more about the ARCHERY study sites. To find out more about the sites that are currently open to recruitment, visit our “Open Sites” page. ...

Read the study protocol for the ARCHERY study in the BMJ Open Journal. "Fifty per cent of patients with cancer require radiotherapy during their disease course, however, only 10%–40% of patients in low-income and middle-income countries (LMICs) have access to it. A shortfall in specialised workforce has been identified as the most significant barrier to expanding radiotherap ...

Watch Dr Aggarwal's presentation from the London Global Cancer Week Event on the 13th November 2023: "Shopping around for cancer care: a global north perspective".  The full recording can be found here (presentation begins at 42:05). ...

An interview with Dr Aggarwal from the Cancer Prevention Group blog. "Dr Ajay Aggarwal is a Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Trust, London, specialising in the delivery of radiation and systemic therapies for cancer. He is also Associate Professor at King’s College London and the London School of Hygiene and Tropical Medicine. He is Co-Director of t ...

Archery is funded by Rising Tide and NIH